Agios Pharmaceuticals Inc (NASDAQ:AGIO) shares, rose in value on Friday, November 01, with the stock price up by 0.99% to the previous day’s close as strong demand from buyers drove the stock to $44.87.
Actively observing the price movement in the last trading, the stock closed the session at $44.43, falling within a range of $43.32 and $45.26. The value of beta (5-year monthly) was 0.746 whereas the PE ratio was 3.95 over 12-month period. Referring to stock’s 52-week performance, its high was $53.28, and the low was $20.40. On the whole, AGIO has fluctuated by 10.63% over the past month.
With the market capitalization of Agios Pharmaceuticals Inc currently standing at about $2.55 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-13.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 36.35M, with a low estimate of 8.6M and a high estimate of 13.6M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 9.94M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that AGIO’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0.10, with the price of AGIO currently trading nearly 2.31% and 0.54% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 51.44, while the 7-day volatility ratio is showing 3.54% which for the 30-day chart, stands at 3.44%. Furthermore, Agios Pharmaceuticals Inc (AGIO)’s beta value is 0.75, and its average true range (ATR) is 1.74.
A comparison of Agios Pharmaceuticals Inc (AGIO) with its peers suggests the former has fared considerably weaker in the market. AGIO showed an intraday change of 0.99% in last session, and over the past year, it grew by 110.66%%.
Data on historical trading for Agios Pharmaceuticals Inc (NASDAQ:AGIO) indicates that the trading volumes over the past 10 days have averaged 0.42 and over the past 3 months, they’ve averaged 469.80K. According to company’s latest data on outstanding shares, there are 55.95 million shares outstanding.
Nearly 3.06% of Agios Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 101.42% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 4.11 million shares as on 2024-10-15, resulting in a short ratio of 6.65. According to the data, the short interest in Agios Pharmaceuticals Inc (AGIO) stood at 732.00 of shares outstanding as of 2024-10-15; the number of short shares registered in 2024-09-13 reached 2.98 million. The stock has risen by 101.48% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the AGIO stock heading into the next quarter.
